Mayne Pharma Group Limited announced the commercial launch of MICROGESTIN 24 FE (norethindrone acetate and ethinyl estradiol tablets, USP, and ferrous fumarate tablets, 1 mg/20 mcg) to customers in the US. MICROGESTIN 24 FE tablets are a generic version of LOESTRIN 24 FE tablets indicated for the prevention of pregnancy. According to IQVIA, the annual US market sales of the generic equivalents were approximately USD 75 million for the twelve months ended October 2020.